MedPath

Corium Innovations, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects

Recruiting
Conditions
MDD
Interventions
Drug: Pharmacokinetic profiles of Selegiline TDS and EMSAM
First Posted Date
2024-09-23
Last Posted Date
2025-02-11
Lead Sponsor
Corium Innovations, Inc.
Target Recruit Count
12
Registration Number
NCT06607744
Locations
🇲🇾

Hospital Ampang, Pandan Mewah, Ampang, Malaysia

🇲🇾

Sarawak General Hospital, Samoran, Sarawak, Malaysia

Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects

Recruiting
Conditions
Multiple Sclerosis
Ulcerative Colitis
First Posted Date
2024-07-30
Last Posted Date
2025-02-11
Lead Sponsor
Corium Innovations, Inc.
Target Recruit Count
24
Registration Number
NCT06528665
Locations
🇲🇾

Hospital Ampang, Ampang, Selangor, Malaysia

© Copyright 2025. All Rights Reserved by MedPath